Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis.

Kley K, Oehr P.

Anticancer Res. 2010 May;30(5):1741-5.

PMID:
20592372
2.

Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.

Bouchelouche K, Capala J, Oehr P.

Curr Opin Oncol. 2009 Sep;21(5):469-74. doi: 10.1097/CCO.0b013e32832d56e4. Review.

3.

Recent developments in urologic oncology: positron emission tomography molecular imaging.

Bouchelouche K, Oehr P.

Curr Opin Oncol. 2008 May;20(3):321-6. doi: 10.1097/CCO.0b013e3282f8b02b. Review.

PMID:
18391633
4.
5.

Imaging of prostate cancer.

Oehr P, Bouchelouche K.

Curr Opin Oncol. 2007 May;19(3):259-64. Review.

PMID:
17414646
6.

'Omics'-based imaging in cancer detection and therapy.

Oehr P.

Per Med. 2006 Feb;3(1):19-32. doi: 10.2217/17410541.3.1.19.

PMID:
29783424
7.
8.

Clinical PET in oncology.

Biersack HJ, Bender H, Ruhlmann J, Oehr P, Guhlke S, Grünwald F.

Rev Esp Med Nucl. 2000 Jun;19(3):219-24. No abstract available.

PMID:
11062087
9.

FDG-PET in clinical oncology: review of the literature and report of one institution's experience.

Oehr P, Ruhlmann J, Biersack HJ.

J Investig Med. 1999 Nov;47(9):452-61. Review. No abstract available.

PMID:
10572375
10.

[Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].

Oehr P, Ruhlmann J, Kozak B, Brock H, Thieme D, Rink H.

Acta Med Austriaca. 1999;26(3):101-3. German.

PMID:
10520378
11.

[Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography].

Ruhlmann J, Oehr P, Bender H, Kozak B, Willkomm P, Bechtold V, Lind P, Biersack HJ.

Acta Med Austriaca. 1998;25(1):1-6. Review. German.

PMID:
9576017
12.

Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.

Ruhlmann J, Schomburg A, Bender H, Oehr P, Robertz-Vaupel GM, Vaupel H, Wolter H, Kozak B, Biersack HJ.

Dis Colon Rectum. 1997 Oct;40(10):1195-204.

PMID:
9336115
13.

Computer modeling of cytokeratin release in clinical oncology.

Oehr P, Vacata V, Ruhlmann J, Rink H.

Anticancer Res. 1997 Jul-Aug;17(4B):3111-2.

PMID:
9329613
14.

[PET scan in general practice for diagnosis of breast carcinoma].

Ruhlmann J, Oehr P, Bender H, Kozak B, Willkomm P, Schräder M, Biersack HJ.

Acta Med Austriaca. 1997;24(2):63-7. German.

PMID:
9273808
15.
16.

The application of immunotargeting into cancer chemotherapy with carboplatin: in vitro and in vivo studies.

Ota Y, Oehr P, Inaba N, Takamizawa H.

Asia Oceania J Obstet Gynaecol. 1993 Dec;19(4):449-57.

PMID:
7510948
17.

Serum TPS versus TPA in Egyptian bladder cancer patients.

Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P.

Int J Biol Markers. 1993 Oct-Dec;8(4):221-6.

PMID:
7511149
19.

Simultaneous determination of urinary CEA, ferritin and TPA in Egyptian bladder cancer patients.

Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P.

Int J Biol Markers. 1992 Oct-Dec;7(4):234-9.

PMID:
1491179
20.

The role of nuclear medicine in oncology.

Biersack HJ, Briele B, Hotze AL, Oehr P, Qian L, Mekkawy MA, Shih WJ.

Ann Nucl Med. 1992 Aug;6(3):131-6. Review.

PMID:
1389887
21.

[Photodynamic laser therapy with antibody-bound dyes. A new procedure in therapy of gynecologic malignancies].

Schmidt S, Wagner U, Schultes B, Oehr P, Decleer W, Ertmer W, Lubaschowski H, Biersack HJ, Krebs D.

Fortschr Med. 1992 Jun 10;110(16):298-301. German.

PMID:
1634171
22.
23.

Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.

Wagner UA, Oehr PF, Reinsberg J, Schmidt SC, Schlebusch HW, Schultes B, Werner A, Prietl G, Krebs D.

Biotechnol Ther. 1992;3(1-2):81-9.

PMID:
1305894
24.

Photodynamic laser therapy of carcinomas--effects of five different photosensitizers in the colony-forming assay.

Schmidt S, Schultes B, Wagner U, Oehr P, Decleer W, Lubaschowski H, Biersack HJ, Krebs D.

Arch Gynecol Obstet. 1991;249(1):9-14.

PMID:
1892426
25.

Tumour imaging with labelled liposomes.

Briele B, Hotze A, Oehr P, Biersack HJ, Rosanowski F, Gorgulla W, Hertberhold C, Harlapp JP.

Lancet. 1990 Oct 6;336(8719):875-6. No abstract available.

PMID:
1976895
26.

[Analysis of tumor markers in lung biopsies and in bronchial lavage].

Vogel J, Loos U, Oehr P.

Pneumologie. 1990 Feb;44 Suppl 1:465-6. German.

PMID:
2164199
27.

Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection.

Reinsberg J, Heydweiller A, Wagner U, Pfeil K, Oehr P, Krebs D.

Clin Chem. 1990 Jan;36(1):164-7.

28.

Radioimmunodetection (RID) with 131 I-labeled monoclonal anti-beta HCG-antibodies in testicular tumors.

Briele B, Bockisch A, Oehr P, Hotze A, Jaeger N, Winter P, Schaefer M, Biersack HJ.

Prog Clin Biol Res. 1990;355:361-3. No abstract available.

PMID:
1704139
29.

[Immunoscintigraphy and immunotherapy].

Biersack HJ, Oehr P, Bockisch A, Hotze A.

Dtsch Med Wochenschr. 1989 Mar 24;114(12):480. German. No abstract available.

PMID:
2924701
30.

Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT.

Biersack HJ, Coenen HH, Stöcklin G, Reichmann K, Bockisch A, Oehr P, Kashab M, Rollmann O.

J Nucl Med. 1989 Jan;30(1):110-2.

31.

Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.

Brökelmann J, Bockisch A, Vogel J, Reinsberg J, Oehr P, Biersack HJ, Krebs D.

Arch Gynecol Obstet. 1989;244(4):193-206.

PMID:
2782949
32.

[Clinical, histological, and immunohistochemical studies of squamous cell carcinomas of the oral mucosa and the prolabium].

Forge K, Vogel J, Ghavami C, Oehr P.

Dtsch Z Mund Kiefer Gesichtschir. 1989 Jan-Feb;13(1):39-43. German.

PMID:
2598505
33.

Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis.

Reinhold U, Pawelec G, Wehrmann W, Kukel S, Oehr P, Kreysel HW.

Acta Derm Venereol. 1989;69(6):497-502.

PMID:
2575322
34.

[Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid].

Loos U, Oehr P, Genske F, Schlack W.

Prax Klin Pneumol. 1988 Jun;42 Suppl 1:235-7. German. No abstract available.

PMID:
3174571
35.

Streptavidin and biotin as potential tumor imaging agents.

Oehr P, Westermann J, Biersack HJ.

J Nucl Med. 1988 May;29(5):728-9. No abstract available.

37.

[Scintigraphic detection of malignancies with radioactively labelled tumor antibodies. Clinical results based on immunohistochemical research].

Biersack HJ, Bockisch A, Vogel J, Oehr P, Hansen HH, Hartlapp J, Biltz H, Jaeger N, Bellmann O.

Dtsch Med Wochenschr. 1987 Feb 27;112(9):341-4. German.

PMID:
2434296
38.

Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.

Biersack HJ, Bockisch A, Oehr P, Knoblich A, Hartlapp J, Biltz H, Jaeger N, Bellmann O, Vogel J, Björklund B, et al.

Nuklearmedizin. 1986 Oct;25(5):167-71.

PMID:
3540857
39.

[Detection of carcinoma in situ of the bladder using TPA antibodies].

Vahlensieck W, Oehr P, Vogel J.

Helv Chir Acta. 1985 Sep;52(3-4):447-50. German. No abstract available.

PMID:
4066372
40.

[Proliferation kinetic and immunohistochemical studies of urothelial atypias/dysplasias and cancers].

Helpap B, Vogel J, Oehr P, Adolphs HD.

Helv Chir Acta. 1985 Sep;52(3-4):451-4. German. No abstract available.

PMID:
3905715
42.

Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia/dysplasia of urinary bladder mucosa.

Helpap B, Vogel J, Oehr P, Adolphs HD.

Virchows Arch A Pathol Anat Histopathol. 1985;406(3):309-22.

PMID:
3923707
43.

[Comparative morphologic and biochemical determinations of CEA and TPA in invasive breast cancers with special reference to lectin histochemistry and hormone receptor status].

Vogel J, Oehr P, Totović V, Bellmann O, Dworak O.

Verh Dtsch Ges Pathol. 1985;69:226-31. German. No abstract available.

PMID:
3913197
45.

[Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].

Biersack HJ, Albrecht W, Oehr P, Rasche A, Winkler C.

Dtsch Med Wochenschr. 1983 Aug 26;108(34):1269-73. German.

PMID:
6411440
46.
47.

[Thyroid hormones during late pregnancy with special reference to the free hormones].

Utsch J, Bellmann O, Oehr P, Rasche A, Biersack HJ, Winkler C.

Nuklearmedizin. 1982 Dec;21(6):236-41. German. No abstract available.

PMID:
6820140
48.

[Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].

Adolphs HD, Oehr P.

Helv Chir Acta. 1982 Aug;49(3-4):307-11. German. No abstract available.

PMID:
7129893
50.

[The action of oxyfedrine on haemodynamics, inotropism and blood perfusion of the partially ischaemic myocardium after digoxin premedication. Studies on anaesthetized dogs (author's transl)].

Hahn N, Raqué B, Holst A, Henn I, von Randow H, Malotki D, Oehr P, Felix R.

Arzneimittelforschung. 1981;31(3):410-4. German.

PMID:
7194664

Supplemental Content

Support Center